Gavin Clark-Gartner
Stock Analyst at Evercore ISI Group
(0)
# 4429
Out of 5,331 analysts
29
Total ratings
36.00%
Success rate
-13.19%
Average return
Main Sectors:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
PRQR ProQR Therapeutics | Initiates Coverage On: Outperform | 5 | 1.99 | 151.26% | 1 | Apr 29, 2025 | |
ABBV AbbVie | Maintains: Outperform | 204 205 | 198.44 | 3.31% | 3 | Apr 28, 2025 | |
MNMD Mind Medicine | Initiates Coverage On: Outperform | 23 | 6.92 | 232.37% | 1 | Jan 28, 2025 | |
CABA Cabaletta Bio | Downgrades: In-Line | 15 6 | 1.34 | 347.76% | 2 | Dec 20, 2024 | |
ARGX argenx | Maintains: Outperform | 675 706 | 649.62 | 8.68% | 4 | Nov 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 179 170 | 63.49 | 167.76% | 9 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 65 65 | 5.41 | 1101.48% | 2 | Aug 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 20 | 4.25 | 370.59% | 1 | Aug 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 201 206 | 165.84 | 24.22% | 1 | Aug 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 62 66 | 43.75 | 50.86% | 2 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 22 | 1.45 | 1417.24% | 1 | Oct 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 20 10 | 1.74 | 474.71% | 1 | May 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 54 60 | 12.2 | 391.8% | 1 | Oct 5, 2022 |